Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Clinical trial NCT07175441 · RECRUITING
Trial details
- NCT number
- NCT07175441
- Sponsor
- Riboscience, LLC.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2027-04-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.